Equine/Horse Arteritis Virus M protein/major envelope antibody and antigen (recombinant protein)

 Download 

Product information

Size： 1mg | 10mg | 100mg

Catalog No.	Description	US $ Price (per mg)	First Order Discount	First Order Discount Price
GMP-VT-P142-Tg001-Ag01	Recombinant Equine/Horse Arteritis Virus M protein/major envelope protein	3090
GMP-VT-P142-Tg001-Ab01	Anti-Equine/Horse Arteritis Virus M protein/major envelope mouse monoclonal antibody (mAb)	1953	20%	1562.4
GMP-VT-P142-Tg001-Ab02	Anti-Equine/Horse Arteritis Virus M protein/major envelope mouse monoclonal antibody (mAb)	1953	20%	1562.4
GMP-VT-P142-Tg001-Ab03	Anti-Equine/Horse Arteritis Virus M protein/major envelope mouse monoclonal antibody (mAb)	1953	20%	1562.4
GMP-VT-P142-Tg001-Ab04	Anti-Equine/Horse Arteritis Virus M protein/major envelope mouse monoclonal antibody (mAb)	1953	20%	1562.4

Shipping Costs: $360–$760
Antibodies: $360 Antigens: $760 (Elevated cost due to antigen heterogeneity, post-translational modifications, structural complexity, and specialized handling.)

Product Description

Cat No. of Products	GMP-VT-P142-Tg001-Ag01
Product Name	Recombinant Equine/Horse Arteritis Virus M protein/major envelope protein
Pathogen	Equine/Horse Arteritis Virus
Target/Biomarker	M protein/major envelope
Expression platform	E.coli
Isotypes	Recombinant Antigen
Bioactivity validation	Anti-Equine/Horse Arteritis Virus M protein/major envelope antibodies binding, Immunogen in Sandwich Elisa, lateral-flow tests, and other immunoassays as control material in Equine/Horse Arteritis Virus level test of animal Equine/Horse with Equine/Horse Arteritis Virus infection.
Tag	His
Products description	Recombinant Equine/Horse Arteritis Virus M protein/major envelope protein was expressed in E.coli - based prokaryotic cell expression system and is expressed with 6 HIS tag at the C-terminus.
Purity	Purity: ≥95% (SDS-PAGE)
Application	Paired antibody immunoassay validation in sandwich Elisa, ELISA, colloidal gold-based Lateral flow immunoassay (LFIA), CLIA, TINIA, POCT and other immunoassays
Formulation & Reconstitution	Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4); For PSB2, reconstituted with 0.9% sodium chloride; For PBS, reconstituted with ddH2O.
Storage	Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Cat No. of Products	GMP-VT-P142-Tg001-Ab01, GMP-VT-P142-Tg001-Ab02, GMP-VT-P142-Tg001-Ab03, GMP-VT-P142-Tg001-Ab04
Product Name	Anti-Equine/Horse Arteritis Virus M protein/major envelope mouse monoclonal antibody (mAb)
Pathogen	Equine/Horse Arteritis Virus
Target/Biomarker	M protein/major envelope
Expression platform	CHO
Isotypes	Mouse IgG
Bioactivity validation	Recombinant Equine/Horse Arteritis Virus M protein/major envelope antigen binding, ELISA validated as capture antibody and detection antibody. Pair recommendation with other anti-Equine/Horse Arteritis Virus antibodies in Equine/Horse Arteritis Virus level test of animal Equine/Horse with Equine/Horse Arteritis Virus infection.
Tag	mFc
Products description	Anti-Equine/Horse Arteritis Virus M protein/major envelope mouse monoclonal antibody (mAb) is a monoclonal antibody produced by CHO. The antibody is ELISA validated as capture antibody and detection antibody pair.
Purity	Purity: ≥95% (SDS-PAGE)
Application	Paired antibody immunoassay validation in sandwich Elisa, ELISA, colloidal gold-based Lateral flow immunoassay (LFIA), CLIA, TINIA, POCT and other immunoassays
Formulation & Reconstitution	Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4); For PSB2, reconstituted with 0.9% sodium chloride; For PBS, reconstituted with ddH2O.
Storage	Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Reference

Validation Data

Click to get more Data / Case study about the product.

Target/Biomarker information

Equine/Horse Viral Arteritis (EVA) is a contagious viral disease in horses caused by Equine/Horse Arteritis Virus (EAV). Infection can go undetected by horse owners/breeders and in herds that were previously unexposed (naïve) abortion rates in pregnant mares can reach up to 70%. Most horses infected with EAV will show minimal if any clinical signs and recover without incident although stallions can become carriers and lifelong shedders of the virus.

About GDU